Institutional investors purchased a net $8.6 million shares of NVO during the quarter ended June 2014, and now own 9.04% of the total float, a percentage that is typical for companies in the Pharmaceuticals: Major industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
JACKSON SQUARE PARTNERS LLC Bought 11.8 Million shares of Novo Nordisk A/S
ARROWSTREET CAPITAL LP Bought 1.6 Million shares of Novo Nordisk A/S
FIDELITY MANAGEMENT & RESEARCH C... Bought 1.4 Million shares of Novo Nordisk A/S